Advicenne S.A. (EPA:ALDVI)
France · Delayed Price · Currency is EUR 1.812
-0.048 (-2.58%)
Jul 14, 2026, 9:13 AM CET
Advicenne Market Cap
Advicenne has a market cap or net worth of €27.06 million as of July 13, 2026. Its market cap has increased by 57.50% in one year.
Market Cap
27.06M
Enterprise Value
44.71M
Revenue
6.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.81
Market Cap Chart
Since December 6, 2017, Advicenne's market cap has decreased from 112.04M to 27.06M, a decrease of -75.85%. That is a compound annual growth rate of -15.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 25.75M | 5.06% |
| Dec 31, 2025 | 24.51M | 1.30% |
| Dec 31, 2024 | 24.20M | -25.97% |
| Dec 29, 2023 | 32.68M | -28.00% |
| Dec 30, 2022 | 45.40M | -51.76% |
| Dec 31, 2021 | 94.11M | 11.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 6, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adocia | 73.18M |
| ABIONYX Pharma | 65.36M |
| MaaT Pharma | 52.39M |
| THX Pharma Société Anonyme | 51.60M |
| Fermentalg | 48.03M |
| Nicox | 33.93M |
| genOway Société anonyme | 22.13M |
| GenSight Biologics | 19.27M |